MD Revenue Group provides specialized, high-performance revenue cycle management for independent pathology practices, multi-site diagnostic laboratory groups, and specialized dermatopathology and molecular testing centers. We eliminate "Technical Erosion" by mastering the complex 2026 shifts in specimen-level intensity, Professional (-26) vs. Technical (-TC) component splits, and the high-complexity documentation required for digital pathology and immunohistochemistry. Our Medical Billing Services are engineered to transform your high-volume diagnostic practice from a reactive back-office task into a proactive capital recovery engine.
For an independent pathology group, the choice to outsource RCM isn't about giving up control, it's about gaining technical leverage against aggressive payers who want to commoditize your high-speed diagnostics. Our Medical Billing & RCM Services provide the administrative backbone required to allow your pathologists to focus on specimen analysis rather than insurance friction.
As you add new physicians, specialized dermatopathologists, or specialized molecular mid-levels, your Revenue Cycle Management scales instantly without the need for additional Credentialing staff or office space.
By catching technical and mathematical errors (like Payer Enrollment gaps or expired CLIA certificates) *before* submission, we dramatically accelerate your cash flow for high-volume diagnostic days.
We build "Audit-Armor" into the foundation of your pathology practice. Our experts ensure that every initial accession, every intraoperative consult, and every IHC record is "Ready for Scrutiny" before it ever leaves your office.
Pathology is a specialty defined by the technical precision of specimen analysis, high-speed procedural throughput, and the absolute requirement for "Diagnostic-to-Billing Parity" for every slide. In 2026, the administrative friction for diagnostic medicine has reached an all-time high, with payers using advanced AI-algorithms to audit "Specimen-Intensity Correlation" and to challenge the "Medical Necessity" of same-day special stains and consultations.
A primary source of revenue erosion for pathology groups is the incorrect selection of surgical pathology levels based on the specimen’s clinical complexity. In 2026, if you process a high-complexity "Level V" specimen but the clinical note lacks the microscopic detail to support it, the claim is auto-downcoded to a "Level IV." We implement Revenue Integrity protocols to ensure that every specimen is captured at its full professional and technical value.
In 2026, many payers have introduced new automated requirements for the "Split-Billing" of pathology when the slide preparation and interpretation are done at different NPIs or locations. Most practices lose 10-12% of their revenue simply by failing to satisfy these technical-modifier requirements for first-pass payment success. MDRG’s Revenue Cycle Management experts specialize in technical "Component-Sync" auditing.
With the rapid expansion of digital pathology codes, payers are requiring increased proof that the computer-assisted component was medically necessary and properly archived for retrospective audit. In 2026, if the "Digital Archive Link" is missing from the technical metadata of the claim, the technical fee is auto-denied.
Topical authority in pathology RCM involves mastering the 88000-series CPT codes and the nuances of high-complexity specimen diagnostics. Our pathology-certified coders ensure every Billing & Revenue Cycle Management (RCM) submission is optimized for 2026 technical success.
Specimen-intensity documentation parity
Same-day bundling & modifier precision
Technical-intensity & CLIA tier mapping
Qualitative vs. Quantitative unit-math
Professional component documentation logic
Meeting the "Outside-Specimen" criteria
Real-time procedural synchronization
In 2026, pathology billing is a battle of "Microscopic Evidence." Payers are no longer just looking for coding errors; they are using AI-driven auditing to challenge the *intensity level* and the *component-splits* of your most frequent specimens. We defend your revenue against these three high-frequency rejection types:
Payer bots often deny high-level surgical claims if they detect a "Template-Gap", where the pathologist provides a definitive diagnosis but fails to include the specific "Complexity Indicators" (e.g., number of lymph nodes, resection margins, or vascular invasion) required for Level VI. In 2026, this is the #1 reason for diagnostic revenue erosion.
For pathology services, payers often trigger technical denials if the report doesn't explicitly link the *signing physician's NPI* to the specific date of service in the LIMS. In 2026, if the "Interpretation Date" lags more than 72 hours behind the "Accession Date" without an extension narrative, the claim is auto-denied.
For newer specialized molecular diagnostics and AI-assisted cell-counting, payers often trigger "Experimental" denials even for standard 2026 protocols.
In 2026, the key to pathology revenue is the "Specimen Intensity Narrative." We help your providers implement "Audit-Armor" charting strategies that signal authority to payer algorithms. This includes using "Trigger Phrases" for visit necessity and automating the capture of specialized procedural technical data.
We help you structure your procedural summaries so that the "Technical Necessity" of a separately identifiable encounter is undeniable to even the most aggressive automated payer bots.
We teach your team how to describe complex immunohistochemistry and special stains in a way that reflects the true "Sequential Intensity" of the Care, maximizing your hourly professional yield.
MDRG acts as your practice’s "Diagnostic RCM Command Center." We focus entirely on Revenue Cycle Management efficiency so you can focus on clinical diagnostics and patient care.
We synchronize with your LIMS-specialized EHR (Mod-Med/EMA, Athena, eCW, NextGen, Orchard, Sunquest, etc.) to establish a clean, high-speed data bridge.
Every specimen claim is scrubbed for 2026 CPT/Diagnosis parity before it hits the clearinghouse. We look for "Level-Mismatch Red-Flags" that AI-payers use to auto-reject high-value surgical pathology blocks.
We don't accept "No." We challenge every technical surgical and diagnostic denial with clinical precision, leveraging our certified coders to file high-level appeals for your most complex cases.
Track your net collections, "Per-Specimen Technical Yield," and payer performance points with total transparency via our secure client portal.
To defend your diagnostic revenue in 2026, your specimen and coordination records must be bulletproof. We provide our pathology clients with a rigorous documentation checklist to ensure compliance:
In a technical audit for a 20-physician independent pathology medical group in the Northeast, MDRG identified a $412,000 annual revenue leakage in their Level V/VI selection (88307/88309) and professional component (-26) billing. The group was failing to correctly document "Complexity Specificity" and was losing the technical value of their separately identifiable evaluation complexities during high-volume hospital-consult weeks.
By implementing Revenue Cycle Management best practices, including real-time "Intensity-Capture Training" for their clinical staff, MDRG was able to: * **Recover $312,000 in uncaptured surgical pathology and interpretative revenue** within the first 6 months. * **Reduce their "Component-Mismatch" Denial Rate** by 72% using specialized technical narratives. * **Accelerate Cash Flow** by reducing their average days in A/R from 48 days to 24 days.
This diagnostic group now operates with "Audit-Armor" protection, knowing that every high-volume specimen analysis is protected from automated payer clawbacks.
Rated 5.0 on Yelp. Read what practice owners say about working with us.
Every word below is a real review, posted publicly on Yelp.
“Our collections has increased tremendously.”
“I have worked with multiple billing companies, and honestly, MD Revenue has been the best experience. They are only a phone call away. When billing issues occur, they are hands-on and dive into the issues to solve them. Our collections has increased tremendously. 5 Star Company. Two thumbs up!!”
Fred A.
San Francisco, CA
“MD Revenue has been exceptional to work with.”
“Today I had a zoom meeting with them and MD Revenue has been exceptional to work with. Their team is extremely professional, clear in their communication, and consistent throughout the process. I highly recommend them to any business owner looking for reliable service.”
Rolando M.
Flushing, NY
“We always know where our claims stand.”
“MD Revenue Group provides good services for our chiropractic practice. Their team handles our billing efficiently and we always know where our claims stand. Communication has been clear and straightforward throughout. We are happy with the service and would recommend them to other practices.”
Dr. Manfred A.
Goodlife Chiro
In the high-volume environment of 2026, your diagnostic practice deserves a revenue cycle that is as precise as your clinical testing. Don't let your "Technical Value" be eroded by primitive billing and administrative friction.
Sent straight to your inbox. We respect medical practice privacy.
Pathology RCM fees range from 2.99% to 6.5% of net collections. The complexity focuses on technical vs. professional component split billing (Modifier 26/TC). We audit laboratory specimen logs to verify that slide counts and diagnostic stains are billed correctly.
Onboarding a pathology group requires mapping LIS laboratory data interfaces. We run diagnostic test exports to verify that slide codes and specimen counts are mapped to correct billing lines, preventing transmission errors.
